OTC:ANEB | Free Cash Flow | Anebulo Pharmaceuticals, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2020-09-30 to 2025-09-30
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-09-30-$1.27M
2025-06-30-$1.65M
2024-09-30-$1.69M
2024-06-30-$2.05M
2023-09-30-$2.73M
2023-06-30-$2.85M
2022-09-30-$2.03M
2022-06-30-$2M
2021-09-30-$777,902.00
2021-06-30-$3.5M
2020-09-30-$134,956.00

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-06-30-$6.35M
2024-06-30-$8.09M
2023-06-30-$9.68M
2022-06-30-$5.44M
2021-06-30-$4.87M